← FDA DRUG APPROVALS

FDA ANDA · ANDA091034

DORZOLAMIDE HYDROCHLORIDE

Sponsor: ZAMBON SPA

APPLICATION
ANDA091034
TYPE
ANDA
ORIGINAL APPROVAL
2013-12-04
LATEST ACTION
2015-04-06
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

DORZOLAMIDE HYDROCHLORIDEDiscontinued
DORZOLAMIDE HYDROCHLORIDE EQ 2% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2015-04-06Labeling · Supplement 1 · standardAP
2013-12-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →